Complete Dissertation

Total Page:16

File Type:pdf, Size:1020Kb

Complete Dissertation VU Research Portal Tumor-associated glycan structures: friend or foe in immunity to cancer? Cornelissen, L.A.M. 2019 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Cornelissen, L. A. M. (2019). Tumor-associated glycan structures: friend or foe in immunity to cancer?. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 09. Oct. 2021 Tumor-associated glycan structures: friend or foe in immunity to cancer? Lenneke A.M. Cornelissen VRIJE UNIVERSITEIT Tumor-associated glycan structures: friend or foe in immunity to cancer? ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad Doctor of Philosophy aan de Vrije Universiteit Amsterdam, op gezag van de rector magnificus prof.dr. V. Subramaniam, in het openbaar te verdedigen ten overstaan van de promotiecommissie van de Faculteit der Geneeskunde op dinsdag 2 juli 2019 om 11.45 uur in de aula van de universiteit, De Boelelaan 1105 door Lenneke Alexandra Maria Cornelissen geboren te Boxmeer promotor: prof.dr. Y. van Kooyk copromotor: dr.ing. S.J. van Vliet Promotiecommissie Promotor Prof. Dr. Y. van Kooyk Amsterdam UMC Copromotor Dr. Ing. S.J. van Vliet Amsterdam UMC Overige leden Prof. Dr. G.J. Adema Radboudumc Dr. T.J. Boltje Radboud University Prof. Dr. K. de Visser Netherlands Cancer Institute Prof. Dr. M. van Egmond Amsterdam UMC Dr. V.L. Thijssen Amsterdam UMC Prof. Dr. M. Wuhrer Leiden University Medical Center The research presented in this thesis was performed at the Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Inflammation Institute, Amsterdam, The Netherlands. The studies described in this thesis were financially supported by Amsterdam UMC. Contents Chapter 1 Introduction Chapter 2 Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells Chapter 3 A bitter sweet symphony: immune responses to altered O-glycan epitopes in cancer Chapter 4 Tn antigen expression contributes to an immune suppressive microenvironment and drives tumor growth in colorectal cancer Chapter 5 Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells Chapter 6 Disruption of sialic acid metabolism drives tumor growth through CD8+ T cell apoptosis Chapter 7 Discussion Appendices Summary Acknowledgements Curriculum vitae List of publications, grants and awards Portfolio Chapter 1 Introduction Lenneke A.M. Cornelissen The multistep development of cancer Cancer cells divide in an uncontrolled manner. Although this is probably the most fundamental trait of cancer, cancer cells must acquire more biological abnormalities to become an invasive tumor. These different characteristics of tumor development were first defined in 20001 as ‘The Hallmarks of Cancer’ and later revised and updated in 20112. At the start of development, cancer cells receive high levels of growth- promoting signals secreted by stromal cells, allowing cancer cells to proliferate in a unrestrained manner1. However, sustained cell proliferation activates cellular programs that negatively regulate cell proliferation, which cancer cells need to circumvent3. In addition, sustained cell growth triggers physiological stress that provokes counteracting responses, including cell senescence and apoptosis. Hence, cellular apoptosis functions as a natural barrier for cancer development4,5. As a consequence, next to evading growth suppressors, cancer cells need to resist cell death to maintain their chronic proliferation state. Non-malignant cells can only undergo a limited number of division cycles, controlling cell growth. Thus to sustain chronic proliferation, cancer cells must acquire replicative immortality6. But, as with normal cells, replication requires nutrients and oxygen, while metabolic waste and carbon dioxide need to be cleared. Neo-vasculature, driven by angiogenesis, is crucial for the tumor to maintain its expansion7, especially once a tumor reaches a bulky size. Moreover, local invasion and distant metastasis allows cancer cells to spread throughout the body8. Metastasis is a feature of late stage tumors in many, if not all, tumor types and reduces the probability of cure considerably. However, besides the changes in expression of cell-cell adhesion molecules, including E-Cadherin9, the main regulators of tumor invasion and metastasis are still largely undescribed and form subjects for future research. The multistep development of cancer enables malignant cells to proliferate, survive and disseminate. Nevertheless, two more hallmarks have recently been added to the revised paradigm of the ‘hallmarks of cancer’2. The first one involves the capability of the cancer cell to reprogram its cellular metabolism in order to deal with nutrients as efficiently as possible to support the enhanced cell proliferation10,11. Secondly, increasing bodies of research have proven that cancer cells evade immune destruction, by dampening the attempts of the immune system to eradicate the tumor cells12. Altogether, the combined hallmarks of cancer portray the complexity of the disease, which clarifies the challenges that come with cancer treatment. Additionally, tumors are very heterogeneous, varying between tumor types as well as within the tumor13, which urges the need to apply cancer treatment in a personalized manner. In the present thesis, we have studied two types of cancer, namely colorectal cancer and melanoma. Therefore, these two types are being introduced in more detail. Colorectal cancer Colorectal cancer (CRC) is a carcinoma of the large intestine, comprising the colon and the rectum. CRC is the third most common cancer in the Netherlands with more than 13.000 new cases every year (www.kwf.nl/kanker). The prevalence of CRC is strongly associated with age and with a western lifestyle including diet, obesity and smoking14. A rapid increase in CRC incidence and mortality is observed in South America, Asia and Eastern Europe, while numbers are declining in more developed countries including USA, Australia, New Zealand and Western Europe. This decline is likely the result of early detection and prevention programs15. Next to alcohol, red as well as processed meat consumption strongly increases the risk of CRC15,16. The exact mechanism underlying the association of meat consumption and the prevalence of CRC are not totally understood. Possible mechanisms include mutagenic and/or carcinogenic compounds 10 present in animal meat17. In addition, red meat is enriched with a monosaccharide that is absent in the human body, but is incorporated in the tissue through dietary intake. Early life exposure of red meat could trigger production of antibodies that are cross reactive against this incorporated monosaccharide. As a consequence, these antibodies can cause inflammation at a later age, which can trigger and promote tumor progression18. CRC typically starts with a polyp that progresses into a carcinoma. The staging of CRC is defined by the size and the extension of the tumor into and through the wall of the large intestine (T1, 2, 3 and 4). In addition, the presence of the cancer cells in the lymph nodes (N0, 1 or 2) and whether it has metastasized (M0 or 1) also determine the staging of CRC. For instance, a tumor, which has grown through the mucosa in the submucosa (T1) and has spread to lymph nodes (N2), but not to distance sites (M0) is categorized as CRC stage III tumor. In the Netherlands, the three year overall survival of patients with stage I and II CRC is 85-95% and 80% for stage III, however the prognosis steeply decreases when entering stage IV, leading to an overall survival of only 20%. Early detection is therefore essential to increase the overall survival rates of CRC patients Melanoma Melanoma is the rarest, but most aggressive type of skin cancer rising from melanocytes present in the skin. Melanoma is the most prevalent cancer type in the Netherlands with more than 15.000 new cases each year (www.kwf.nl/kanker). The primary cause of skin cancer is unprotected exposure to ultraviolet radiation from the sun or artificial sources. Ultraviolet radiation can damage DNA, induce gene mutations, inflammation and oxidative stress, all of which are known to promote tumorigenesis19. Protection can be achieved by either sunscreen or natural pigmentation in the skin (melanin). Melanoma staging is dependent on the thickness of the tumor as well as the presence of ulceration, mitosis, and metastasis. Till stage II the primary melanoma thickness is less than 4 mm with or without ulceration. When regional metastasis
Recommended publications
  • Lectin Free Diet
    THERMO-TECH INC. Lectins Free Diet Lectins are proteins in plants that have been associated with both positive and negative health effects. Some plant-based foods, such as beans and legumes, whole grains, nuts, seeds and certain vegetables contain a high amount of lectins. Lectins are a type of protein that, in humans, may help cells interact with one another. Some scientists also believe that lectins provide a form of defense in plants to keep insects away. These proteins also contain nitrogen, which is needed for plants to grow. While many parts of plants contain lectins, the seed is the part that people eat most often. Lectins may impact health in multiple ways, ranging from digestive disturbances (a dysbiotic condition of the gut) to chronic disease risk (inflammation and autoimmune disease including: celiac disease, psoriasis, diabetes, rheumatoid arthritis, MS and Parkinson's Disease to name a few). They have also been shown to cause red blood cells to cluster together thus not carrying the nutrients and oxygen to our cells this can cause malnutrition although our diet is varied and plentiful. Lectins are categorized as anti-nutrients since they block the absorption of some nutrients. Lectins may cause an upset stomach when plant foods are eaten uncooked. They are also the reason why it can be dangerous to eat undercooked legumes. The lectins in red kidney beans is called phytohaemagglutinin is responsible for red kidney bean poisoning, which results from eating raw or undercooked kidney beans. According to the United States Food and Drug Administration (FDA), consuming just four raw kidney beans could cause symptoms including severe nausea, vomiting, and diarrhea.
    [Show full text]
  • Binding and the Effect of the Red Kidney Bean Lectin, Phytohaemagglutinin, In
    Downloaded from https://www.cambridge.org/core British Journal of Nutrition (2006), 95, 105–115 DOI: 10.1079/BJN20051612 q The Authors 2006 Binding and the effect of the red kidney bean lectin, phytohaemagglutinin, in . IP address: the gastrointestinal tract of suckling rats 170.106.202.58 Ann Linderoth1*, Olena Prykhod’ko1, Bo Ahre´n2, Frida Fa˚k1, Stefan G. Pierzynowski1 and Bjo¨rn R. Westro¨m1 1Department of Cell and Organism Biology, Lund University, Helgonava¨gen 3B, SE-223 62 Lund, Sweden , on 2Department of Medicine, University Hospital, Lund University, Lund, Sweden 29 Sep 2021 at 02:15:37 (Received 7 April 2005 – Revised 8 July 2005 – Accepted 17 July 2005) Enteral exposure of suckling rats to phytohaemagglutinin (PHA) has been shown to induce growth and precocious functional maturation of the gastrointestinal tract. The aim of the present study was to explore the mechanism of this action. Suckling rats, 14 d old, were fed a single dose , subject to the Cambridge Core terms of use, available at of PHA (0·05 mg/g body weight) or saline. The binding of PHA to the gut epithelium and its effect on the morphology and functional properties of the gut and pancreas were studied up to 3 d after treatment. Initially, at 1–24 h, the PHA bound along the gut mucosal lining, resulting in dis- turbed gut morphology with villi shortening and rapid decreases in disaccharidase activities and macromolecular absorption capacity. During a later phase, between 1 and 3 d, the PHA binding had declined, and an uptake by enterocytes was observed.
    [Show full text]
  • Part I: Abstracts of Members' Proffered
    ABSTRACTS OF MEMBERS PAPERS 401 PART I: ABSTRACTS OF MEMBERS' PROFFERED PAPERS ENHANCEMENT OF CHEMICALLY- Pregnant rats were injected with ethyl- INDUCED NEOPLASIA BY PROXI- nitrosourea to induce cerebral gliomas in a MAL ENTERECTOMY. R. C. N. WIL- high proportion of the offspring. With a dose LIAMSON, F. L. R. BAUER and R. A. MALT, of 40-50 mg/kg body weight the average United Bristol Hospitals and MlVassachusetts latent period for these brain tumours is 246 General Hospital, Boston, U.S.A. (Introduced days. Cultures have been prepared at by M. 0. Symes). different times after transplacental exposure Azoxymethane-induced tumours in the but before a tumour is visible. It has been rat, morphologically indistinguishable from reported previously (Roscoe and Claisse those arising in man, affect the duodenum, (1976) Nature, Lond., 262, 314) that there is jejunum and colon, but usually spare the a marked difference in the behaviour of ileum (Ward, J. M. (1975) Vet. Pathol., 12, cultures prepared 138-145 days p.i. and 2 165). Proximal small-bowel resection (PSBR) days p.i. These experiments have been causes prompt ileal hyperplasia, with a lesser extended and are reported here. Cultures response in the colon. To test the possible prepared 111-112 days p.i. were similar to adjuvant effect of postresectional hyper- those derived 138-145 days p.i. They con- plasia on intestinal carcinogenesis, rats tained cells like those found in tumour (n= 76) were submitted to 5000 PSBR 10 cultures which can predominate in culture days after the last of 16 weekly injections of and are tumourigenic.
    [Show full text]
  • Lymphocyte Responses to DR1/4 Restricted Ann Rheum Dis: First Published As 10.1136/Ard.53.3.171 on 1 March 1994
    Annals of the Rheumatic Diseases 1994; 53: 171-177 171 Lymphocyte responses to DR1/4 restricted Ann Rheum Dis: first published as 10.1136/ard.53.3.171 on 1 March 1994. Downloaded from peptides in rheumatoid arthritis Margot A Skinner, Lisa Watson, Arie Geursen, Paul L J Tan Abstract examination of the synovium has shown a Objective-To determine whether analog prominent infiltrate of lymphocytes, the and unrelated DR1/4 binding peptides majority of which are activated T cells.2 In alter DR1/4 restricted responses of addition, several experimental treatment peripheral blood lymphocytes (PBL) from strategies which act primarily through their patients with rheumatoid arthritis (RA). effect on T cells are reported to be effective in Methods-PBL from 25 patients with RA the treatment of RA.' 3 and 12 healthy controls were cultured with The association of RA with major histo- DR1/4 restricted peptides of the influenza compatibility genes is well established4 and the haemagglutinin, amino acids 307-319 HILA DR4 (DRB1*04) and DR1 (DRBl*01) (HA) and matrix proteins, amino acids genes involved is well documented.5 Disease 17-29 (IM). Responses were determined susceptibility has been localised to the third by 3H-thymidine uptake proliferation hypervariable region of the i chain of DR assays and limiting dilution analysis. and in white groups is most commonly Competitor peptides were analogs HA- associated with Dw4 (DRB1*0401), R312 and HA-K313 differing from HA by one containing the amino acid sequence amino acid at the 312 or 313 position LLEQKRAA at positions 67-74 and VG at respectively or unrelated peptides which residues 85-86.5 This disease-associated bind to DR1I/4.
    [Show full text]
  • Dry Kidney Beans Need to Be Boiled
    THE OHIO STATE UNIVERSITY OHIO STATE UNIVERSITY EXTENSION OHIO AGRICULTURAL RESEARCH AND DEVELOPMENT CENTER April 12, 2013 Dry kidney beans By Martha Filipic 614-292-9833 need to be boiled [email protected] Editor: A few weeks ago, I contacting their doctor. Other types of beans also This column was reviewed by Linnette Goard, field specialist soaked some dry kidney contain PHA, but it’s much more in food safety, selection and beans to prepare them concentrated in red kidney beans. For management for Ohio State for some chili. My sister example, the unit of measurement University Extension, the told me that before for the toxin is called “hau,” for outreach arm of the College “hemagglutinating unit.” Raw red of Food, Agricultural, and adding them to the kidney beans have anywhere from Environmental Sciences. chili, I should boil them 20,000 to 70,000 hau, but that drops to 200 to 400 hau when the beans to make sure the beans Communications and are fully cooked — not enough to be wouldn’t make us sick. I Technology a problem. White kidney beans, or Strategic Communications did, but was that really cannellini beans, contain only about 2021 Coffey Road necessary? one-third of the toxin as red kidney Columbus, OH 43210-1044 614-292-2011 You’ve got a knowledgeable sister. beans. Broad beans, or fava beans, Many people don’t know the risk contain just 5 to 10 percent of what’s 208 Research Services posed by dry red kidney beans when in red kidney beans. Building they’re not cooked properly.
    [Show full text]
  • Phytohaemagglutinin-M (PHA-M) Liquid
    Ref : FT.L3010an Page : 1/2 Technical data sheet Version date : 13/02/2014 Phytohaemagglutinin-M (PHA-M) liquid CAT N° : L3010 Storage conditions : Store frozen medium at -20°C After thawing, the PHA-M is stable for at least 1 month at +2/+8°C. The PHA-M may appear cloudy at +2/+8°C, but this turbidity has no effect on the activity of the product. Shelf life : 36 months Composition : After thawing, each ml of the solution contains 5 to 10 mg of protein. Recommended use : - Respect storage conditions of the product - Do not use the product after its expiry date - Store the product in a dry area - Wear clothes adapted to the manipulation of the product to avoid contamination (e.g. : gloves, mask, hygiene cap, overall…) - Protect the product from any form of humidity - Use, in one time, after opening, the entire quantity of product of the container, without making a concentrated solution (to avoid the formation of precipitates). If it is not possible, close the container immediately after sampling the quantity of powder required. - Supplements can be added prior to sterile filtration of the medium or aseptically introduced to sterile medium (respect the final concentration of the media). The nature of the supplements may affect storage conditions and shelf life of the medium. The product is intended to be used in vitro, in laboratory only. Do not use it in therapy, human or veterinary applications. Application : Phytohaemagglutinin is a lectin extracted from red kidney beans (Phaseolus vulgaris). The protein consists of two molecular species : a leucoagglutinin (PHA-L)and an erythroagglutinin (PHA-E).
    [Show full text]
  • Effect of the 13-Adrenoceptor Agonist Clenbuterol and Phytohaemagglutinin on Growth, Protein Synthesis and Polyamine Metabolism of Tissues of the Rat 'S
    Br. J. Pharmacol. (1992), 106, 476-482 '." Macmillan Press Ltd, 1992 Effect of the 13-adrenoceptor agonist clenbuterol and phytohaemagglutinin on growth, protein synthesis and polyamine metabolism of tissues of the rat 'S. Bardocz, D.S. Brown, G. Grant, A. Pusztai, J.C. Stewart & R.M. Palmer Rowett Research Institute, Bucksburn, Aberdeen AB2 9SB 1 The kidney bean lectin, phytohaemagglutinin (PHA), induced a marked atrophy of skeletal muscle which was evident from the changes in tissue composition (protein, RNA, DNA and polyamine content) and from the reduction in weight and protein synthesis of hind leg muscles of rats fed on kidney bean-diets for four days. The P-adrenoceptor agonist, clenbuterol, induced skeletal muscle hypertrophy by transiently stimulating protein synthesis. As a consequence, the muscle loss caused by a short exposure to PHA was, in part, ameliorated by clenbuterol treatment. 2 Cardiac muscle was affected to a lesser extent than skeletal muscle by both clenbuterol and the lectin. However, there was evidence that protein synthesis in heart was reduced by PHA. 3 PHA had opposite effects on the gut, the lectin-induced hyperplasia of the jejunum was accompanied by a large increase in protein synthesis. Clenbuterol alone had no effect on the jejunum whereas a combination of PHA and clenbuterol appeared to exacerbate the effect of the lectin on gut. 4 Both the lectin-induced gut growth and the hypertrophy of skeletal muscle caused by clenbuterol were preceded by the accumulation of polyamines in the respective tissues. Of particular note was the observation that a significant increase in the proportion of the intraperitoneally injected '4C-labelled spermidine or putrescine taken up by the growing tissues could be detected by the second day.
    [Show full text]
  • Binding and the Effect of the Red Kidney Bean Lectin, Phytohaemagglutinin, in the Gastrointestinal Tract of Suckling Rats
    Downloaded from https://www.cambridge.org/core British Journal of Nutrition (2006), 95, 105–115 DOI: 10.1079/BJN20051612 q The Authors 2006 Binding and the effect of the red kidney bean lectin, phytohaemagglutinin, in . IP address: the gastrointestinal tract of suckling rats 170.106.33.22 Ann Linderoth1*, Olena Prykhod’ko1, Bo Ahre´n2, Frida Fa˚k1, Stefan G. Pierzynowski1 and Bjo¨rn R. Westro¨m1 1Department of Cell and Organism Biology, Lund University, Helgonava¨gen 3B, SE-223 62 Lund, Sweden , on 2Department of Medicine, University Hospital, Lund University, Lund, Sweden 26 Sep 2021 at 12:43:14 (Received 7 April 2005 – Revised 8 July 2005 – Accepted 17 July 2005) Enteral exposure of suckling rats to phytohaemagglutinin (PHA) has been shown to induce growth and precocious functional maturation of the , subject to the Cambridge Core terms of use, available at gastrointestinal tract. The aim of the present study was to explore the mechanism of this action. Suckling rats, 14 d old, were fed a single dose of PHA (0·05 mg/g body weight) or saline. The binding of PHA to the gut epithelium and its effect on the morphology and functional properties of the gut and pancreas were studied up to 3 d after treatment. Initially, at 1–24 h, the PHA bound along the gut mucosal lining, resulting in dis- turbed gut morphology with villi shortening and rapid decreases in disaccharidase activities and macromolecular absorption capacity. During a later phase, between 1 and 3 d, the PHA binding had declined, and an uptake by enterocytes was observed.
    [Show full text]
  • Porifera Lectins: Diversity, Physiological Roles and Biotechnological Potential
    Mar. Drugs 2015, 13, 5059-5101; doi:10.3390/md13085059 OPEN ACCESS marine drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Review Porifera Lectins: Diversity, Physiological Roles and Biotechnological Potential Johan Gardères 1,2,3, Marie-Lise Bourguet-Kondracki 1, Bojan Hamer 2, Renato Batel 2, Heinz C. Schröder 3 and Werner E. G. Müller 3, * 1 Unité Molécules de Communication et Adaptation des Microorganismes, UMR 7245 CNRS, Muséum National d’Histoire Naturelle, CP 54, 57 rue Cuvier, Paris 75005, France; E-Mails: [email protected] (J.G.); [email protected] (M.-L.B.-K.) 2 Laboratory for Marine Molecular Biology, Center for Marine Research, Ruđer Bošković Institute, G. Paliaga 5, 52210 Rovinj, Croatia; E-Mails: [email protected] (B.H.); [email protected] (R.B.) 3 ERC Advanced Investigator Grant Research Group at Institute for Physiological Chemistry, University Medical Center of Johannes Gutenberg University Mainz, Duesbergweg 6, Mainz D-55128, Germany; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-6131-39-25910; Fax: +49-6131-39-25243. Academic Editor: Anake Kijjoa Received: 30 April 2015 / Accepted: 27 July 2015 / Published: 7 August 2015 Abstract: An overview on the diversity of 39 lectins from the phylum Porifera is presented, including 38 lectins, which were identified from the class of demosponges, and one lectin from the class of hexactinellida. Their purification from crude extracts was mainly performed by using affinity chromatography and gel filtration techniques. Other protocols were also developed in order to collect and study sponge lectins, including screening of sponge genomes and expression in heterologous bacterial systems.
    [Show full text]
  • In Vivo Fluorescence Imaging of E-Selectin: Quantitative Detection of Endothelial Activation in Arthritis
    In Vivo Fluorescence Imaging of E-Selectin: Quantitative Detection of Endothelial Activation in Arthritis A thesis submitted for the degree of PhD by Luke Gompels August 2010 Kennedy Institute of Rheumatology Faculty of Medicine Imperial College SUPERVISORS Dr Ewa Paleolog Prof. Dorian Haskard 1 Abstract Rheumatoid arthritis (RA) is a chronic progressive systemic inflammatory disease, characterized by synovial inflammation and localized destruction of cartilage and bone. Heterogeneity in the clinical presentation of RA and uncertainty about which patients will respond to treatment makes diagnosis and management challenging. Fluorescent imaging in the near infrared (NIR) spectrum significantly decreases tissue autofluorescence offering unique potential to detect specific molecular targets in vivo. E-selectin or endothelial adhesion molecule-1 (ELAM-1), a 115kDa glycoprotein induced on endothelial cells in response to pro-inflammatory cytokines involved in RA, such as interleukin (IL)-1 and tumour necrosis factor (TNF. E-selectin has been well validated as a potential biomarker of disease activity. My study aimed to investigate whether E-selectin targeted optical imaging in vivo could be developed as a sensitive, specific and quantifiable preclinical molecular imaging technique, and also whether this approach could be used to delineate the molecular effects of novel therapies. I utilised anti-E-selectin antibody labelled with NIR fluorophore in a mouse model of paw swelling induced by intra-plantar injection of TNFand in acute collagen-induced arthritis (CIA) in DBA/1 mice, a widely used model of RA. E-selectin generated signal, localised to points of maximal clinical inflammation in the inflamed mouse paw in both models with significant differences to control antibody.
    [Show full text]
  • Normal Human Alveolar Macrophages Obtained by Bronchoalveolar Lavage Have a Limited Capacity to Release Interleukin-1
    Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. M D Wewers, … , P B Bitterman, R G Crystal J Clin Invest. 1984;74(6):2208-2218. https://doi.org/10.1172/JCI111647. Research Article Interleukin-1 (IL-1) is a mediator released by stimulated mononuclear phagocytes that is thought to play an important role in modulating T and B lymphocyte activation as well as in contributing to the febrile response and other inflammatory processes. Circulating mononuclear phagocytes, blood monocytes, readily release IL-1 when stimulated. However, the ability of lung mononuclear phagocytes, alveolar macrophages, to dispose of the large daily burden of inhaled antigens without stimulating an inflammatory response suggests that the release of IL-1 by alveolar macrophages may differ significantly from that of blood monocytes. To evaluate this hypothesis, normal autologous alveolar macrophages, obtained by bronchoalveolar lavage, were compared with blood monocytes for their ability to release IL-1 in response to a standard stimulus, lipopolysaccharide (LPS). Alveolar macrophages were found to be at least 1,000 times less sensitive to LPS than blood monocytes. Furthermore, alveolar macrophages released significantly less IL-1 than blood monocytes (26 +/- 11 vs. 128 +/- 21 U/10(6) cells X 24 h, respectively, after stimulation with 10 micrograms/ml of LPS, P less than 0.001). This difference was not due to the release of substances by macrophages, which inhibited lymphocyte proliferation in response to IL-1, or to degradation of IL-1 by macrophages. Culturing macrophages in the presence of indomethacin and dialysis of macrophage supernatants did not affect the difference, and culturing macrophages with monocytes […] Find the latest version: https://jci.me/111647/pdf Normal Human Alveolar Macrophages Obtained by Bronchoalveolar Lavage Have a Limited Capacity to Release Interleukin-1 Mark D.
    [Show full text]
  • Galectin-3: Is This Member of a Large Family of Multifunctional Lectins (Already) a Therapeutic Target?
    Expert Opinion on Therapeutic Targets ISSN: 1472-8222 (Print) 1744-7631 (Online) Journal homepage: https://www.tandfonline.com/loi/iett20 Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target? Antonio Romero & Hans-Joachim Gabius To cite this article: Antonio Romero & Hans-Joachim Gabius (2019): Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target?, Expert Opinion on Therapeutic Targets, DOI: 10.1080/14728222.2019.1675638 To link to this article: https://doi.org/10.1080/14728222.2019.1675638 Accepted author version posted online: 01 Oct 2019. Submit your article to this journal View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=iett20 Publisher: Taylor & Francis & Informa UK Limited, trading as Taylor & Francis Group Journal: Expert Opinion on Therapeutic Targets DOI: 10.1080/14728222.2019.1675638 Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target? Antonio Romero1* and Hans-Joachim Gabius2* 1Structural and Chemistry Department, Centro de Investigaciones Biológicas (CIB), CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain 2Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians- University Munich, 80539 Munich, Germany Corresponding author: Dr. A. Romero (Research Professor of the Spanish Research Council, CSIC): Phone: +34 91 1098044, Fax: +34 91 5360432, e-mail: [email protected] Prof. Dr. Dr. h.c. H.-J. Gabius: Tel.+49-89-2180 2290, Fax: +49-89-2180 992290, e-mail: [email protected] or [email protected] Accepted Manuscript Information Classification: General ABSTRACT Introduction: The discoveries that sugars are a highly versatile platform to generate biochemical messages and that glycan-specific receptors (lectins) are a link between these signals and their bioactivity explain the interest in endogenous lectins such as galectins.
    [Show full text]